The Wellness Group and Coulson Capital Launch Wellgineering — A Research Lab and Venture Studio Building the Future of Human and Planetary Wellness
Miami, FL — January 15, 2025 — The Wellness Group, in partnership with Coulson Capital, today announced the official launch of Wellgineering, a next-generation research lab and venture studio uniting elite bioengineers, chemists, biometric specialists, and AI researchers to create breakthrough technologies at the intersection of biotechnology and artificial intelligence.
Designed to transform innovation into impact, Wellgineering combines the scientific depth of a research institute with the operational speed of a venture accelerator — developing, incubating, and launching category-defining companies that advance human wellness, livestock performance, and precision agriculture.
Engineering the Future of Wellness
Wellgineering operates as a scientific and commercial engine within The Wellness Group ecosystem, developing proprietary intellectual property and spinning out ventures that apply biointelligence to real-world health, performance, and sustainability challenges.
“True innovation requires the courage to challenge what is, in order to engineer what could be,” said Foster Coulson, Founding Partner of Wellgineering and CEO of The Wellness Group. “Wellgineering is where science, creativity, and conviction converge — a place where the next generation of wellness technologies will be imagined, built, and brought to life.”
From Concept to Commercialization
Unlike traditional R&D labs, Wellgineering goes beyond discovery. Each initiative is designed for translation and scale, moving from prototype to market through in-house venture incubation. The studio supports founders and scientists through every phase — from research and IP development to funding, regulatory strategy, and go-to-market execution.
By aligning deep scientific capability with venture-building expertise, Wellgineering aims to redefine how biotech and AI innovations are created, funded, and deployed across industries that shape the future of human and planetary health.
Areas of Focus
Wellgineering’s early research and commercialization initiatives span:
Human wellness and longevity technologies powered by biomarker sensing and adaptive AI;
Livestock and agricultural biotech, including sustainable feed systems and bioelectronic interfaces;
AI-driven bioengineering platforms for precision diagnostics, drug delivery, and metabolic optimization.
About Wellgineering
Wellgineering.io is a research lab and venture studio backed by The Wellness Group and Coulson Capital, dedicated to engineering the future of wellness. Partnering with visionary founders at the intersection of biotechnology, AI, and human performance, Wellgineering transforms scientific breakthroughs into scalable companies. With in-house expertise spanning bioengineering, chemistry, biometric sensing, and machine learning, Wellgineering provides both capital and infrastructure — turning bold ideas into transformative technologies.